Waltham, MA, US - June 8, 2023 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, has marked a significant achievement with the completion of its cGMP manufacturing facilities expansion project in Waltham, Massachusetts. This growth extends the firm's existing track record in delivering state-of-the-art biopharmaceutical solutions to partners worldwide.
The advanced biomanufacturing suites feature a microbial fermentation train that supports up to 450 liters and a mammalian production train with the capacity to manage volumes up to 2,000 liters. In addition to this, the facility is equipped with a fully automated fill and finish line, significantly enhancing the capability for high-throughput filling into diverse formats such as vials, syringes, and cartridges.
Northway Biotech's CEO, Prof. Vladas Algirdas Bumelis, reflected on this milestone, stating, "By successfully integrating the GMP suites into our US operations, we've made a strategic leap forward. This enables us to deliver comprehensive solutions across two separate sites and positions us optimally to serve our partners with an unprecedented degree of speed and efficiency."
In honor of this significant expansion, Northway Biotech hosted two grand opening events on June 6th and June 8th. The inaugural event, graced by a delegation of Lithuanian biotechnology companies attending the BIO 2023 conference, was led by Ms. Aušrinė Armonaitė, the Minister of the Economy and Innovation of the Republic of Lithuania. The second event, held two days later, welcomed Northway Biotech's clients, prospective customers, and esteemed Boston officials to explore the state-of-the-art facilities, fostering a platform for valuable discourse within the biotech community.
About Northway Biotech
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and located in Vilnius, Lithuania, London, United Kingdom, and in Waltham, MA, US. Further information can be found on Northway's website www.northwaybiotech.com
Press release PDF
Please find our press release offered for download in a PDF form below: